Page last updated: 2024-09-05

lapatinib and Chordoma

lapatinib has been researched along with Chordoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asquith, CRM; Drewry, DH; East, MP; Havener, TM; Johnson, GL; Laitinen, T; Morris, DC; Naegeli, KM; Wells, CI; Zuercher, WJ	1
Bozzi, F; Casale, A; Casali, PG; Conca, E; Crippa, F; Gronchi, A; Lo Vullo, S; Mariani, L; Marrari, A; Messina, A; Morosi, C; Negri, T; Palassini, E; Palmerini, E; Pilotti, S; Stacchiotti, S; Tamborini, E	1
Bozzi, F; Conca, E; Dagrada, G; Gronchi, A; Manenti, G; Messina, A; Panizza, P; Pierotti, MA; Pilotti, S; Stacchiotti, S; Tamborini, E	1

Trials

1 trial(s) available for lapatinib and Chordoma

Article	Year
Phase II study on lapatinib in advanced EGFR-positive chordoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Chordoma; Disease-Free Survival; Drug Administration Schedule; ErbB Receptors; Female; Humans; Lapatinib; Male; Middle Aged; Quinazolines; Sacrum; Skull Base; Treatment Outcome	2013

Article

Year

Phase II study on lapatinib in advanced EGFR-positive chordoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:7

Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Chordoma; Disease-Free Survival; Drug Administration Schedule; ErbB Receptors; Female; Humans; Lapatinib; Male; Middle Aged; Quinazolines; Sacrum; Skull Base; Treatment Outcome

2013

Other Studies

2 other study(ies) available for lapatinib and Chordoma

Article	Year
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma. Journal of medicinal chemistry, 2019, 05-09, Volume: 62, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chordoma; Drug Design; ErbB Receptors; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines	2019
Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies. Neuro-oncology, 2014, Volume: 16, Issue:1 Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Chordoma; ErbB Receptors; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Lapatinib; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Recurrence, Local; Quinazolines; Sacrum; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2014

Article

Year

Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.

Journal of medicinal chemistry, 2019, 05-09, Volume: 62, Issue:9

Topics: Aminoquinolines; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chordoma; Drug Design; ErbB Receptors; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines

2019

Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.

Neuro-oncology, 2014, Volume: 16, Issue:1

Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Chordoma; ErbB Receptors; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Lapatinib; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Recurrence, Local; Quinazolines; Sacrum; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2014